Popular Trials
CDK 4/6 Inhibitor
Ribociclib + Everolimus for Dedifferentiated Liposarcoma and Leiomyosarcoma
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial tests a combination of two drugs, Ribociclib and Everolimus, in patients with advanced DDL and LMS who have not responded to previous treatments. Ribociclib blocks proteins that help cancer grow, while Everolimus stops cancer cells from multiplying. Everolimus is an oral mTOR inhibitor that is approved for various cancers, including renal cell carcinoma and breast cancer.
CDK4/6 Inhibitor
Abemaciclib for Liposarcoma
Recruiting3 awardsPhase 2
New York, New York
This trial is testing the effects of the drug Abemaciclib on cancer growth. Researchers hope to learn if the drug can delay cancer growth or shrink tumors. Abemaciclib is not FDA approved, but has shown promise in shrinking tumors in patients with breast cancer, lymphoma, and lung cancer.
CAR T-cell Therapy
Lifileucel for Uveal Melanoma
Recruiting1 awardPhase 1
Harrison, New York
This trial is testing lifileucel, a treatment that uses a patient's own immune cells, in patients with advanced uveal melanoma. The treatment aims to boost the body's natural ability to fight cancer. Lifileucel has shown promising results in treating melanoma that does not respond to other treatments.
Popular Filters
Trials for Cancer Patients
Alkylating agents
Chemotherapy + Radiation for Soft Tissue Sarcoma
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.
Immunotherapy
Etrumadenant + Zimberelimab for Sarcoma
Recruiting1 awardPhase 2
Basking Ridge, New Jersey
This trial is testing a combination of two drugs, etrumadenant and zimberelimab, to treat patients with advanced dedifferentiated liposarcoma (DDLS). These patients have cancer that has come back, spread, or cannot be removed by surgery. Etrumadenant stops cancer cells from growing, while zimberelimab helps the immune system fight the cancer.
Trials for STS Patients
Alkylating agents
Chemotherapy + Radiation for Soft Tissue Sarcoma
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.
Alkylating agents
Combination Therapy for Soft Tissue Sarcoma
Recruiting1 awardPhase 1 & 2
Memphis, Tennessee
This trial aims to study the treatment of non-rhabdomyosarcoma soft tissue sarcoma in both intermediate-risk and high-risk patients. The primary objectives include assessing the survival rates and pharmacokin
Alkylating agents
Seclidemstat + Chemotherapy for Ewing Sarcoma
Recruiting1 awardPhase 1
Los Angeles, California
This trial tests seclidemstat alone and with other drugs in patients with specific types of sarcoma, especially those who haven't responded to other treatments. The treatment aims to block cancer growth and use chemotherapy to kill cancer cells.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.